HAMP and chronic kidney disease: A conclusion on the basis of our study, the first one using the general cohort of patients prior to surgery, and table 2, five studies in CKD patients and one study in patients undergoing chemotherapy, can be that serum hepcidin levels may serve as a predictor for the response to iron therapy and correlates with serum ferritin.